Global Prosthetic Heart Valves Market Size To Reach $24.2 Billion By 2035

Global prosthetic heart valves market is projected to grow from $10.6 billion in 2025 and is projected to reach $24.2 billion by 2035, growing at a CAGR of 8.6% during the forecast period 2026-2035. The global prosthetic heart valves market is witnessing steady growth driven by the increasing prevalence of cardiovascular diseases and the aging population worldwide. Advancements in valve design, including improvements in materials and durability, have enhanced clinical outcomes and patient safety, encouraging broader adoption. Minimally invasive procedures, particularly transcatheter valve implantation, are becoming more common, offering reduced recovery times and lower procedural risks. Hospitals and specialized cardiac centers remain the primary settings for these interventions, supported by expanding healthcare infrastructure and trained clinical personnel. Rising awareness among healthcare providers and patients about the benefits of timely valve replacement is also contributing to market expansion.

Browse the full report description of “Prosthetic Heart Valves Market Size, Share & Trends Analysis Report by Type (Mechanical Heart Valves and Biological/Tissue Heart Valves), and by End-Users (Hospitals and Ambulatory Centers) Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/prosthetic-heart-valve-market

In addition to demographic and clinical factors, technological innovation continues to shape the market. The development of valves with improved hemodynamic performance and reduced complication rates has increased physician confidence and procedural success. Emerging markets are seeing higher adoption due to growing access to healthcare services and investments in cardiac care facilities. Strategic initiatives by manufacturers, including product approvals and geographic expansion, are enabling wider availability of prosthetic valves. Trends such as enhanced imaging guidance and integration with minimally invasive delivery systems further support clinical adoption. Overall, the market is influenced by a combination of patient needs, procedural advancements, and healthcare infrastructure growth.

Competitive Landscape of the Prosthetic Heart Valves Market

The key players in the prosthetic heart valves market are Edwards Lifesciences Corp., Medtronic plc., Abbott Laboratories, Boston Scientific Corp., and LivaNova PLC, among others. The prosthetic heart valve market is dominated by several established medical device manufacturers that have a strong presence in both surgical and transcatheter valve segments. These companies focus on continuous innovation, regulatory approvals, and geographic expansion to maintain competitiveness. Their product portfolios include a range of mechanical and tissue valves, supporting adoption across hospitals and specialized cardiac centers. Collaborative initiatives with healthcare providers and ongoing clinical research further reinforce their influence in shaping market trends and driving procedural advancements.

• In December 2025, Edwards Lifesciences Corporation confirmed that its SAPIEN M3 transcatheter mitral valve replacement system is expected to receive FDA approval in early 2026. This would mark the commercialization of a new category within transcatheter valve therapies, expanding beyond aortic into mitral applications.

• In September 2025, Medtronic plc launched the Evolut™ FX+ transcatheter valve in India following regulatory approval. The product focuses on improving coronary access and procedural outcomes, reflecting continued iteration within its TAVR product line.

• In January 2025, Abbott Laboratories introduced the Navitor Vision transcatheter heart valve in India, targeting patients with severe aortic stenosis. This launch reflects continued portfolio expansion in minimally invasive valve technologies and strengthens Abbott’s competitive position in emerging markets.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Type
  • By End-Users
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - Edwards Lifesciences Corp., Medtronic plc., Abbott Laboratories, Boston Scientific Corp., and LivaNova PLC, among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Prosthetic Heart Valves Market Report Segment

By Type

• Mechanical Heart Valves
• Biological/Tissue Heart Valves

By End-Users

• Hospitals
• Ambulatory Centers

Global Prosthetic Heart Valves Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/prosthetic-heart-valve-market